Verista, a leading transformative compliance and automation solutions organization for the life sciences industry, recently acquired Hawkins Point, a leader in life sciences business and technology services. The acquisition expands and improves Verista’s scope of services and capabilities, adding research and development (R&D) and commercialization technology capabilities for large pharma, early-stage biotech and medical device companies, while broadening its geographic footprint to better support its clients’ growing needs. The Hawkins Point acquisition was led by private equity sponsor Lightview Capital, which originally invested in Clarke in 2015, and Maranon Capital, which provided debt financing.
Read the full article: Verista Acquires Hawkins Point to Supercharge Business and Technology Prowess Across the Drug Development Lifecycle //
Source: https://www.prnewswire.com/news-releases/verista-acquires-hawkins-point-to-supercharge-business-and-technology-prowess-across-the-drug-development-lifecycle-301219394.html